WAKIX Time-to-Onset & Cardiovascular Safety Data Presented at AAN 2021
“These analyses further characterize the efficacy and safety profile of WAKIX and its broad clinical utility for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy.”
Read More